{
  "id": 6251880,
  "title": "ZeroHarm Sciences Secures $7.2M to Scale Nano-Nutraceuticals Globally",
  "url": "https://urgent.news/2026/09/08/zeroharm-sciences-secures-7-2m-to-scale-nano-nutraceuticals-globally",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-08T07:32:04.000Z",
  "source": {
    "name": "Ventureburn",
    "slug": "ventureburn",
    "url": "https://ventureburn.com/zeroharm-sciences-secures-funding/"
  },
  "original_language": "en",
  "account": "Hyderabad-based ZeroHarm Sciences, a nutrition startup, has successfully raised $7.2 million ($65 crore) in an early-stage funding round, led by Kotak Alternate Asset Managers and Alkemi Growth Capital. Founded in 2020 by Sachin and Shweta Darbarwar, the company specializes in plant-based supplements, leveraging patented nano-formulation technology to enhance bioavailability and controlled release at reduced dosages. The startup's vertical integration includes sourcing medicinal plants from over 10,000 farmers and manufacturing in Guwahati, supporting a portfolio of 60-plus SKUs aimed at heart health, diabetes management, and oncology support. With the additional capital, ZeroHarm Sciences intends to expand into the US, UK, and Middle East markets, while also developing a 'Trust over Promise' platform to validate supplement efficacy through measurable health outcomes for its over 300,000 customers.",
  "summary": "Scaling Nano-Nutraceuticals Hyderabad-based nutrition startup ZeroHarm Sciences has closed a $7.2 million (₹65 crore) early-stage funding round. The investment was led by Kotak Alternate Asset Managers, which contributed ₹40 crore The post ZeroHarm Sciences Secures $7.2M to Scale Nano-Nutraceuticals Globally appeared first on Ventureburn .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}